Rockwell Medical stock fell 7.05 percent after CEO sale

Published on 10/07/2026 at 02:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Rockwell Medical stock saw CEO Mark Strobeck sell 1,000 shares at USD 8.42 on October 1. Q2 revenue rose 10.6 percent to USD 17.78 million.

RMTI, US7743743004, Illustration mit AI erstellt.

Rockwell Medical stock (ISIN US7743743004) was last at USD 7.65 on Nasdaq on October 6, 2026, down 7.05 percent from the prior close. The latest company-specific filing showed CEO Mark Strobeck selling 1,000 shares at USD 8.42 on October 1, 2026, under a Rule 10b5-1 trading plan, according to StockTitan.

CEO sale meets a weak session

The transaction left Strobeck with 61,349 directly held shares, the same filing said. Because the sale was executed under a pre-arranged trading plan, the filing describes a disclosed transaction rather than a discretionary market call.

The October 6 price of USD 7.65 stood inside RMTI's current 52-week range of USD 4.89 to USD 12.90. The stock therefore remained USD 5.25 below its yearly high, while the session volume reached 64,808 shares.

Quarterly revenue offers a counterpoint

Rockwell Medical reported second-quarter 2026 revenue of USD 17.78 million, up 10.6 percent from the year-earlier period, according to ToAlpha. The company develops, manufactures, commercializes, and distributes hemodialysis products for dialysis providers, according to its investor relations page.

The revenue comparison gives investors a more constructive operating signal than the daily price action. It also places the insider transaction in a business that is still expanding quarterly sales while the share price remains well below its 52-week high.

Consensus target stays at USD 20

MarketBeat lists a Hold consensus based on two analyst ratings, with one Buy and one Sell. Its average, highest, and lowest price target are all USD 20.00, according to MarketBeat in an update covering October 6, 2026.

Against the USD 7.65 Nasdaq price on October 6, 2026, the consensus target lies 161.44 percent above the price. The wide gap reflects the split analyst view and the small scale of the company, making quarterly execution and future losses central checkpoints for the stock.

RMTI stock ends near USD 8

Rockwell Medical stock was last at USD 7.65 on Nasdaq on October 6, 2026, at 4:00 p.m. ET, with a market capitalization of USD 30.2 million and volume of 64,808 shares. The next market question is whether revenue growth can continue to narrow the distance between the operating business and the USD 20.00 consensus target.